Simultaneous total occlusion of two coronary arteries associated with use of drospirenone-ethinyl estradiol (oral contraceptive)
Although the use of oral contraceptives is associated with an increased risk of venous thromboembolic disease, the risk of myocardial infarction (MI) is unclear. A new, third-generation contraceptive agent, drospirenone-ethinyl estradiol, which contains less estrogen and a new progestogen, drospiren...
Main Authors: | Hüsnü Atmaca, Diyar Köprülü, Tuncay Kiriş, Gönül Zeren, İrfan Şahin |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2018-01-01
|
Series: | Türk Kardiyoloji Derneği Arşivi |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-57606 |
Similar Items
-
Ultrasound-Assisted Extraction, Followed by Gas Chromatography–Mass Spectrometry for the Simultaneous Quantification of Ethinyl Estradiol and Drospirenone in Contraceptive Formulations
by: Javier Peña, et al.
Published: (2023-06-01) -
Effectiveness and safety assessment of drospirenone/ethinyl estradiol tablet in treatment of PCOS patients: a single center, prospective, observational study
by: Li Li, et al.
Published: (2020-02-01) -
Evaluating the Cognitive Impacts of Drospirenone, a Spironolactone-Derived Progestin, Independently and in Combination With Ethinyl Estradiol in Ovariectomized Adult Rats
by: Stephanie V. Koebele, et al.
Published: (2022-05-01) -
Interaction of a caffeine overdose with clinical doses of contraceptive ethinyl estradiol in a young woman
by: Koichiro Adachi, et al.
Published: (2024-01-01) -
PREMENSTRUAL SYNDROME: FROM THEORY TO PRACTICE
by: O. V. Yakushevskaya
Published: (2016-12-01)